Morning sickness/nausea and vomiting in pregnancy

Effect of Sharbat-i-Anar Sheerin in Nausea and Vomiting in Pregnancy â?? An open observational study - NVP

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030812

Enrollment

Registered

2021-01-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O268- Other specified pregnancy relatedconditions Health Condition 2: O268- Other specified pregnancy relatedconditions

Interventions

Intervention1: Sharbat-i-Anar Sheerin: The ingredients of Sharbat-i-Anar sheerin are Aab-i-Anar sheerin and nabat safaid (both in equal quantity).Sharbat will be prepared as per the method mentioned i

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women in age group of 18-35 years with singleton fetus between 6-12 weeks of gestation with nausea and vomiting with mild to moderate (3-12) PUQE score.2

Exclusion criteria

Exclusion criteria: Patient with Severe NVP requiring fluid therapy and hospitalization, H/o peptic ulcer, gastroenteritis, pancreatitis, cholecystitis, appendicitis, renal stone, Systemic diseases eg.HTN, DM, Thyroid dysfunction, Multiple Pregnancy, ectopic pregnancy, molar pregnancy.

Design outcomes

Primary

Measure	Time frame
Reduction in PUQE scoreTimepoint: Reduction in PUQE score	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactIsmath Shameem

national institute of unani medicine

dr.ismaths@gmail.com9449977008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026